PReS-FINAL-2045: Mutational analysis of sialic acid acetylesterase (siae) in juvenile idiopathic arthritis (JIA)

被引：0
|
作者：
E Tsitsami
E Sevdali
M Speletas
机构：
[1] University of Athens,1st Department of Pediatrics, School of Medicine
[2] Children's Hospital "Aghia Sophia",Department of Immunology & Histocompatibility, School of Medicine
[3] University of Thessaly,undefined
来源：
Pediatric Rheumatology | / 11卷 / Suppl 2期
关键词：
Autoimmune Disease; Sialic Acid; Juvenile Idiopathic Arthritis; Genetic Alteration; Biological Significance;
D O I：
10.1186/1546-0096-11-S2-P58
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PReS-FINAL-2170: Work disability in adult patients with juvenile idiopathic arthritis (JIA)
    C Goldenstein-Schainberg
    J Gordo
    R Krieger
    LE Paula
    N Aikawa
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [2] PReS-FINAL-2062: The need for conducting different rehabilitation complexes for patients with juvenile idiopathic arthritis (JIA)
    TA Shelepina
    IP Nikishina
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [3] PReS-FINAL-2096: Herpes virus infections in patients with juvenile idiopathic arthritis (JIA) treated with etanercept
    R Nicolai
    E Cortis
    L Ravà
    C Bracaglia
    M Pardeo
    A Insalaco
    PS Buonuomo
    F De Benedetti
    AE Tozzi
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [4] PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients
    P Lu
    J Hsu
    C Keane
    S Fettner
    J Wang
    N Ruperto
    O Harari
    HI Brunner
    F De Benedetti
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [5] PReS-FINAL-2020: Cell type specific transcriptome analysis in patients with enthesitis related arthritis category of juvenile idiopathic arthritis (JIA-ERA)
    A Aggarwal
    A Myles
    P Gaur
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [6] PReS-FINAL-2043: Cardiac involvement in juvenile idiopathic arthritis
    E Rossetto
    E Benelli
    E Mascheroni
    E Berton
    A Taddio
    L Lepore
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [7] PReS-FINAL-2142: Predictors of persistent remission following etanercept (ETN) withdrawal in patients with juvenile idiopathic arthritis (JIA)
    F Perfetti
    F Gesualdo
    V Messia
    A Insalaco
    C Bracaglia
    M Pardeo
    R Nicolai
    L Meli
    F De Benedetti
    S Magni Manzoni
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [8] PReS-FINAL-2112: Mapping the treatment effect of infliximab on a case of refractory anterior uveitis related to juvenile idiopathic arthritis (JIA)
    V Miranda
    C Zilhão
    P Menéres
    M Guedes
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [9] PReS-FINAL-2067: How does the self-experienced HRQOL work for children with JIA - juvenile idiopathic arthritis in Stockholm?
    K Berggren
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [10] PReS-FINAL-2031: Hyaluronic acid is a marker of active arthritis, but not systemic inflammation in systemic juvenile idiopathic arthritis
    B Hugle
    M Olsson
    N Fischer
    M Herrmann
    K Lindblad-Toh
    JP Haas
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
12345